Vit Vasista
2020
In 2020, Vit Vasista earned a total compensation of $1.9M as EVP, Chief Financial Officer at Regenxbio, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $181,275 |
|---|---|
| Option Awards | $1,230,788 |
| Salary | $453,188 |
| Other | $16,388 |
| Total | $1,881,639 |
Vasista received $1.2M in option awards, accounting for 65% of the total pay in 2020.
Vasista also received $181.3K in non-equity incentive plan, $453.2K in salary and $16.4K in other compensation.
Rankings
In 2020, Vit Vasista's compensation ranked 5,789th out of 13,090 executives tracked by ExecPay. In other words, Vasista earned more than 55.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,789 out of 13,090 | 56th |
Division Manufacturing | 2,383 out of 5,620 | 58th |
Major group Chemicals And Allied Products | 952 out of 2,253 | 58th |
Industry group Drugs | 824 out of 1,953 | 58th |
Industry Biological Products, Except Diagnostic Substances | 200 out of 411 | 51st |
Source: SEC filing on April 7, 2022.
Vasista's colleagues
We found four more compensation records of executives who worked with Vit Vasista at Regenxbio in 2020.